Hall D P, Gruentzig A R
Cardiol Clin. 1985 Feb;3(1):37-48.
Despite continued efforts at disease prevention, coronary artery disease remains accountable for more than 500,000 deaths per year in the United States. Surgical intervention has assumed a well-deserved role over the past 16 years in disease palliation and receives wide application. More recently, PTCA has emerged as a proven technique for coronary revascularization that can be applied to a large group of patients with coronary artery disease. Clearly complementing bypass surgery, percutaneous dilatation offers certain advantages such as reduced emotional pain and suffering, sizable economic savings, and reduced time lost from work. As diagnostic technology continues to improve, the goal of early disease recognition and gentle nonsurgical resolution may well be accomplished in many individuals suffering from coronary artery disease.
尽管在疾病预防方面不断努力,但在美国,冠状动脉疾病每年仍导致超过50万例死亡。在过去16年里,外科手术干预在疾病缓解方面发挥了当之无愧的作用,并得到广泛应用。最近,经皮冠状动脉腔内血管成形术(PTCA)已成为一种成熟的冠状动脉血运重建技术,可应用于大量冠状动脉疾病患者。经皮扩张术明显是对搭桥手术的补充,具有某些优势,如减轻精神痛苦、节省可观的经济费用以及减少误工时间。随着诊断技术不断改进,对于许多患有冠状动脉疾病的个体而言,早期疾病识别和温和的非手术治疗这一目标很可能会实现。